Efficacy and safety of moxifloxacin on community acquired pneumonia
Abstract
Objective To evaluate the clinical efficacy and safety of moxifloxacin on community acquired pneumonia.MethodsPatients with community acquired pneumonia were treated with moxifloxacin or mezlocillin in a randomized controlled study.A total of 72 patients were enrolled in the study,32 patients in moxifloxacin group,32 patients in mezlocillin group.All patients had been treated for 7～14 days.ResultsThe effective rates of moxifloxacin group and mezlocillin group were 88.89% and 86.11% respectively.Patients with community acquired pneumonia have better tolerances and dependences to moxifloxacin.ConclusionMoxifloxacin is effective and safe for the treatment of patients with community acquired pneumonia.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 72 participants or records.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.